Evidence map›Paper›PMID 17507642›Full record

Trial reportNeurorehabilitation and neural repair

Validity of the walking scale for spinal cord injury and other domains of function in a multicenter clinical trial.

John F Ditunno, Hugues Barbeau, Bruce H Dobkin, Robert Elashoff, Susan Harkema, Ralph J Marino, Walter W Hauck, David Apple, D Michele Basso, Andrea Behrman and 6 more

Abstract readMulticenter StudyRandomized Controlled TrialValidation Study
In one paragraph

Trial report in Neurorehabilitation and neural repair. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Walking Ability Outcome Measures in Individuals with Spinal Cord Injury: A Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Dolutegravir Reduces Human T-Cell Lymphotropic Virus Type 1 Proviral Load and Improves Neurological Outcomes in a Phase 2 Controlled Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Trial
  9. Trial
  10. Trial
  11. Short-term results of intrathecal injection of low-dose bupivacaine in outpatients with chronic low back and lower extremity pain.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2019
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

John F DitunnoDepartment of Rehabilitation Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. John.Ditunno@jefferson.edu
Hugues Barbeau
Bruce H Dobkin
Robert Elashoff
Susan Harkema
Ralph J Marino
Walter W Hauck
David Apple
D Michele Basso
Andrea Behrman
Daniel Deforge
Lisa Fugate
Michael Saulino
Michael Scott
Joanie Chung
Spinal Cord Injury Locomotor Trial Group

Funding

WESTERN REHABILITATION RESEARCH NETWORKR24HD039629 · NICHD · UNIVERSITY OF WASHINGTON · PI ANDERSON, MARJORIE E · 2000 to 2004
$4.8M
LOCOMOTOR THERAPY TRIAL FOR SPINAL CORD INJURYU01HD037439 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DOBKIN, BRUCE HARVEY · 1999 to 2003
$3.3M
NICHD NIH HHS R24 HD039629NICHD NIH HHS R24 HD39629NICHD NIH HHS U01 HD037439PHS HHS R01 H37439
6 · The paper itself

Abstract

objectiveTo demonstrate criterion (concurrent and predictive) and construct validity of the Walking Index for Spinal Cord Injury (WISCI) scale and other walking measures in the Spinal Cord Injury Locomotor Trial (SCILT).

designProspective multicenter clinical trial of a walking intervention for patients with acute traumatic spinal cord injury (SCI). PARTICIPANTS/

methodsBody weight-supported treadmill training was compared to overground mobility training in 146 patients with incomplete SCI (C4 to L3) enrolled within 8 weeks of onset and treated for 12 weeks. Primary outcome measures were the Functional Independence Measure (FIM), 50-foot walking speed (50FW-S), and 6-minute walking distance (6MW-D), tested 3, 6, and 12 months after entry. Secondary measures were the Lower Extremity Motor Score (LEMS), Berg Balance Scale (BBS), WISCI, and FIM locomotor score (LFIM), assessed at 6 centers by blinded observers. Data for the 2 arms were combined since no significant differences in outcomes had been found.

resultsCorrelations with WISCI at 6 months were significant with BBS (r = .90), LEMS (r = .85), LFIM (r = .89), FIM (r = .77), 50FW-S (r = .85), and 6MW-D ( r = .79); similar correlations occurred at 3 and 12 months. Correlations of change scores from baseline WISCI were significant for change scores from baseline of LEMS/BBS/LFIM. Correlation of baseline LEMS and WISCI at 12 months were most significant (r = .73). The R(2) of baseline LEMS explained 57% of variability of WISCI levels at 3 months.

conclusionConcurrent validity of the WISCI scale was supported by significant correlations with all measures at 3, 6, and 12 months. Correlation of change scores supports predictive validity. The LEMS at baseline was the best predictor of the WISCI score at 12 months and explained most of the variance, which supported both predictive and construct validity. The combination of the LEMS, BBS, WISCI, 50FW-S, and LFIM appears to encompass adequate descriptors for outcomes of walking trials for incomplete SCI.

Indexed as

Disability EvaluationAdolescentAdultAgedCrutchesExercise TestExercise TherapyFemaleGait Disorders, NeurologicHumansMaleMiddle AgedProspective StudiesSpinal Cord InjuriesTreatment OutcomeWalkers

Identifiers

PMID17507642
PMCPMC4080923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.